Masui, Y., Yoshida, T., Higashiyama, R. I., Yagishita, S., Ohuchi, M., Masuda, K., Shinno, Y., Matsumoto, Y., Mizutani, T., Okuma, Y., Horinouchi, H., Koyama, S., Yamamoto, N., Hamada, A., Goto, Y. (2026). Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.12138